US President Donald Trump yesterday made several false statements regarding progress in the fight against COVID-19. Among them was a claim that an anti-malaria drug had been approved for use. It has not. It is going to be tested in a clinical trial, along with other drugs. The president also misspoke about patients’ “right to try” new drugs, and potential compassionate use in otherwise hopeless cases. Host Marco Werman tries to clear things up by speaking with bioethicist, Arthur Caplan of New York University.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.